Vaidlok Bio Science Private Limited
Sells cosmetic articles, incorporated in 2020, based in Gujarat.
2020 | Surat, Gujarat (India) | Active
Vaidlok Bio Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -174.31%
- Profit Growth 81.42%
- Ebitda 87.87%
- Net Worth -25.03%
- Total Assets 11.45%
About Vaidlok Bio Science
Vaidlok Bio Science Private Limited (VBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 March 2020 (Four years and 11 months 10 days old ). Its registered office is in Surat, Gujarat, India.
The Corporate was formerly known as Vaidshri Bio Science Private Limited. The Company is engaged in the Consumer Goods Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jatin Rabheru and Ghansyam Rathod serve as directors at the Company.
Company Details
- Location
Surat, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909GJ2020PTC113268
- Company No.
113268
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Consumer Goods
Who are the key members and board of directors at Vaidlok Bio Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatin Rabheru  | Additional Director | 25-May-2023 | Current |
| Ghansyam Rathod | Additional Director | 25-May-2023 | Current |
Financial Performance of Vaidlok Bio Science.
Vaidlok Bio Science Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 174.31% decrease. The company also saw a substantial improvement in profitability, with a 81.42% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaidlok Bio Science?
In 2022, Vaidlok Bio Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vaidlok Bio Science?
Vaidlok Bio Science has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaidlok Bio Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaidlok Bio Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
